HLA-DQ8 (A1*0301, B1*0302) and -DQ2 (A1*0501, B1*0201) are both associated with diseases such as insulin-dependent diabetes mellitus and coeliac disease. We used the technique of pool sequencing to look at the requirements of peptides binding to HLA-DQ8, and combined these data with naturally sequenced ligands and in vitro binding assays to describe a novel motif for HLA-DQ8. The motif, which has the same basic format as many HLA-DR molecules, consists of four or five anchor regions, in the positions from the N-terminus of the binding core of n, n ⍣ 3, n ⍣ 5/6 and n ⍣ 8, i.e. P1, P4, P6/7 and P9. P1 and P9 require negative or polar residues, with mainly aliphatic residues at P4 and P6/7. The features of the HLA-DQ8 motif were then compared to a pool sequence of peptides eluted from HLA-DQ2. A consensus motif for the binding of a common peptide which may be involved in disease pathogenesis is described. Neither of the disease-associated alleles HLA-DQ2 and -DQ8 have Asp at position 57 of the β-chain. This Asp, if present, may form a salt bridge with an Arg at position 79 of the α-chain and so alter the binding specificity of P9. HLA-DQ2 and -DQ8 both appear to prefer negatively charged amino acids at P9. In contrast, HLA-DQ7 (A1*0301, B1*0301), which is not associated with diabetes, has Asp at β57, allowing positively charged amino acids at P9. This analysis of the sequence features of DQbinding peptides suggests molecular characteristics which may be useful to predict epitopes involved in disease pathogenesis.
Introduction
Type I insulin-dependent diabetes mellitus (IDDM) is a polywhereas other HLA-DQ alleles like DQB1*0602 and DQB1*0301 are protective (2) . However, it is clear that the genic disease. Familial clustering of the disease can be explained by sharing of alleles at 10 or more loci, the interaction of the HLA-DR and -DQ alleles is important in contributing to overall susceptibility: a study on Sardinian HLA region appearing to contribute the major portion (1) . Observations from different racial groups, including black diabetics revealed DRB1*0405-DQ8 to be a susceptible haplotype, DRB1*0402-DQ8 neutral and DRB1*0403-DQ8 and caucasian populations, indicate that both HLA-DQ8 (A1*0301, B1*0302) and -DQ2 (A1*0501, B1*0201) are positprotective (3). It is not known how particular HLA molecules interact ively associated with IDDM, and act as susceptibility alleles, and contribute to disease susceptibility in IDDM, but it is Methods reasonable to suppose that this reflects peptide binding Preparation of class II alleles motifs. Subtle polymorphism, such as the Gly/Val dimorphism at position 86 of the HLA-DRβ chain, have already been Epstein-Barr virus-transformed B cell lines Cox and BM-14 (homozygous for HLA-DR3/DQ2 and -DR4/DQ8 respectively) shown to influence other diseases (4, 5) . Identification of the type of peptides bound by the susceptibility molecules were grown up to 10 11 cells in roller bottles with RPMI 1640 supplemented with 10% FCS, L-glutamine and antibiotics. HLA-DQ2 and -DQ8 may contribute to the understanding of IDDM pathogenesis. Furthermore, knowledge of the motif
The cells were then lysed with 3% NP-40 in PBS containing leupeptin 1 µg/ml, pepstatin 1 µg/ml and 5 mM EDTA. The requirements of peptides binding to these molecules may allow modification of the immune response in these lysate was spun at 100,000 g for 90 min. The supernatant was passed over a pre-column of Sepharose CL 4B followed conditions.
Most studies of motifs, which are important for peptide by an affinity column with cyanogen bromide-activated Sepharose beads linked to the monoclonal anti-DQ 1a3 (16). binding to HLA class II molecules, have been carried out using HLA-DR molecules. Relatively little work has been done After the supernatant was run down the column, it was washed extensively before elution of the DQ molecules with 0.05 M on HLA-DQ binding peptides (6, 7) . The techniques employed include pool and individual peptide sequencing of naturally diethylamine (pH 11.5). The DQ molecules were immediately neutralized with 1 M Tris (pH 6.8) and concentrated by bound peptides, and in vitro binding assays of synthesized peptides to purified class II molecules. X-ray crystallographic ultrafiltration (Centriprep; Amicon, Beverly, MA). The purity was analysed by 12% SDS-PAGE. data for HLA-DR1 show that the peptide is bound to an extended conformation in a binding groove made up from Pool sequencing parts of the α-and β-chain in the heterodimer (8) . Unlike class I molecules, which bind peptides nine or 10 amino Naturally processed peptide ligands were released from the HLA-DQ2 or -DQ8 alleles by acid elution with 0.1% acids in length, class II molecules bind peptides of variable size, usually 12-20 amino acids in length. Although the trifluoroacetic acid. The HLA molecules were separated from the peptides by ultrafiltration using Centricon-10 terminal parts of the peptide extend beyond the ends of the groove, there appears, like the class I molecules, to be a Microconcentrator (Amicon). The peptides were then separated by reverse-phase HPLC, and the dominant peaks core binding region of nine amino acids. Certain pockets in the binding groove accommodate amino acid side chains removed and sequenced individually. The remaining peptide pool was analysed using a liquid protein sequencer (494A; from the bound peptide. These amino acids are known as anchor residues. For HLA-DR1, anchor residues assume Applied Biosystems, Foster City, CA) over 15 cycles; cysteine was not quantitated and the yield of histidine was negligible. positions (from the N-terminus of the core binding region of the peptide) n, n ϩ 3, n ϩ 5, n ϩ 6 and n ϩ 8, known
Transformation of the pool sequence data respectively as P1, P4, P6, P7 and P9. For HLA-DQ molecules, there is some evidence that similar restrictions may apply
The pool sequence data were organized using a procedure previously described to generate a matrix of relative enrichwhen looking at the binding of a particular peptide (9, 10) . Furthermore, computer modelling using the known sequences ments (17). Briefly, the amount of each amino acid at each cycle is described as a percentage of the total quantity of all of the DQ alleles and comparing them to the DR alleles has suggested a similar pattern of binding (11, 12) . amino acids in that cycle. The average of each amino acid is then taken over the 15 cycles and each position in the A further technique which has been used to look at the requirements for binding to a particular HLA molecule is pool cycle is described as a proportion of the average. sequencing (13, 14) . Here, all the naturally processed peptides Peptide binding assays are released from purified HLA molecules and sequenced en masse by Edman degradation. Patterns of enrichment for
The candidate peptides were synthesized by F-Moc chemistry using an automated synthesizer (Advanced ChemTech 396 particular amino acids are examined at each cycle of the degradation. These data can then be used in conjunction Multiple Peptide Synthesizer). Their purity was assessed by reverse-phase HPLC and the concentration measured using with known ligands to attempt motif prediction.
There have been two previously reported motifs for HLAa bicinchoninic acid assay. The binding assay was carried out using the principle of DQ8 (10, 15) . The first paper suggested a positively charged amino acid for the P1 anchor position and an Ala or Gly at competition with a promiscuously binding biotinylated CLIP peptide from the invariant chain (96-114) (I*) or a biotinylated P6; this motif was based purely on sequencing and aligning 11 eluted peptides. The more recent report used in vitro peptide from HLA-B7 α-chain (150-164) (B7*). The test peptide was dissolved in DMSO and the initial serial 1:10 dilutions binding data of a GAD 65 -derived peptide and analogues to define contact residues: this motif, in contrast to that above, were made in pH 5 buffer (0.02 M 2-N-morpholinoethanesulphonic acid in 0.1 M NaCl and 0.02% azide). The peptide did not allow positively charged residues at P1, but did tolerate Ala at P6. In this study, we describe for the first time was incubated at 37°C with I*/B7* (0.06-0.1 µg) and the class II protein (0.15 µg). The mixture was neutralized with 1 M Tris the use of pool sequencing data to help define the DQ8 motif and in vitro binding assays to validate the findings. We also (pH 8.0) and transferred to wells precoated with anti-DQ antibody. The mixture was incubated for 1 h and the wells compare the pool sequence data for HLA-DQ8 with that of -DQ2 and -DQ7, and attempt to relate the salient differences washed thoroughly with PBS containing 1% Tween (PBS-T) and then PBS alone. to sequence variation in the α-or β-chains of these molecules. The pool sequencing data for HLA-DQ8 is shown in Table 3 ,
Thyroid peroxidase neg neg Ͻ0.02 (632-644) and the generated matrix of relative enrichments is shown in HLA-DRB1*0402 neg -0.13 Table 4 . The matrix takes into account the diminishing yields (99) (100) (101) (102) (103) (104) (105) (106) (107) (108) that are measured in each cycle of the Edman degradation.
For instance, if the yields of aspartate are assessed over the (383) (384) (385) (386) (387) (388) (389) (390) (391) (392) (393) (394) (395) (396) (397) (398) 15 cycles, it is not apparent that there is enrichment in cycles
13, 14 and 15 which is seen clearly in the probability matrix.
The data from the matrix show enrichment of different amino (99) (100) (101) (102) (103) (104) (105) (106) (107) (108) acids in different cycles of degradation, indicated by scores of Ͼ1. The core binding region most likely covers cycles 4/5
The anchors at P1 and P9 are taken from the alignment of ligands shown in Table 6 .
to 13/14 (14). If the enrichment occurs over more than one cycle, this may reflect an anchor residue fitting into a pocket of the binding groove of the DQ molecule. There is clearly a preference for charged and polar residues in the early and The plate was developed with avidin-horseradish peroxidlate cycles, and aliphatic amino acids in the central region ase (ExtrAvidin; Sigma, St Louis, MO)/biotinylated anti-avidin covering cycles 7-10. Enrichment patterns are seen in cycles (Sigma)/ExtrAvidin and developed with 100 µl of o-phenylene 4/5, 7/8, 9/10 and 12-14 that could represent requirements diamine (0.4 mg/ml) in phosphate citrate buffer. The reaction for key pockets in the binding groove of P1, P4, P6/7 and P9 was terminated with 12.5% sulphuric acid; the absorption respectively. This is shown in Table 5 . was measured at 492 nm. The concentration of unlabelled A combination of the pool sequencing data with the binding peptide required to inhibit 50% of the binding (IC 50 ) of the assays and a matching of known ligands, shown in Table 6 , I*/B7* was calculated in µM.
suggests key features for the motif include P1: negative, polar All the binding assays were repeated in triplicate and the or bulky hydrophobic residues; P4/6/7: aliphatic; and P9 mean calculated. negative or polar.
Results

Discussion
Sequenced ligands and preliminary in vitro binding to HLAThis paper describes the use of pool sequencing to help DQ8 elucidate the motif for HLA-DQ8. The motif suggested from these data consists of negatively charged or polar residues Two individual peptide peaks were separated and sequenced: TPTEKDEYACRVNH (β 2 -microglobulin 91-105) and at either end of the core in P1 and P9, and mainly aliphatic amino acids in the central pockets. The large P1 pocket also LNEDLRSWTAAD (HLA-B7 150-161). These two peptides were synthesized (β 2 -m 91-104 and HLA-B7 150-164), along favours bulky hydrophobic residues, as is the case for many class II alleles (7) . with the reported HLA-DQ8-restricted T cell epitope p21ras 51-66 (Q to L position 61) (18), and the suggested ligands There is a clear preference for negatively charged amino acids at P1 and P9. This is suggested by looking at the initial Plasmodium falciparum CP 383-398 and thyroid peroxidase 632-644 (Frode Vartdal, pers. commun.). Also, two peptides binding data from Table 1 : the peptides which have negative amino acids at both these putative anchor positions have far covering polymorphic sequences from HLA-DR molecules were synthesized (HLA-DRB1*0401 99-108 and -DRB1*0402 lower IC 50 's. This tendency to favour negative charges in the P1 of HLA-DQ8 has not been described previously but is 99-108).
The binding affinities were measured in vitro against the borne out by matching motifs of known ligands (Table 6) , as well as the binding data of the B7 peptides ( Table 2 ). The CLIP peptide, which has already been shown to bind to the HLA-DQ8 molecule (15). The results are shown in Table 1 .
parent B7 peptide binds with the highest affinity. This could be due to non-specific enhancement of the binding by the Each peptide described above bound to the HLA-DQ8 molecule, with the HLA-B7 peptide binding with the highest affinity.
N-and C-terminal extensions, as has been observed before with the CLIP peptide (19). Further evidence favouring nega-A notable exception is peptide HLA-DRB1*0401 (β99-108) which has the N-terminal amino acids Gln and Lys, rather tively charged P1 amino acids is the 300-fold increase in binding of the peptide derived from the HLA-DRB1*0402 than the negatively charged Asp and Glu found in the binding peptide HLA-DRB1*0402 (β99-108).
(DERAAVDTYC) compared to that from DRB1*0401 (QKRAAVDTYC). These preliminary binding data suggest a key role for negatively charged anchors at P1 and P9, and this theory was Chicz et al. (15) described a preference for positively charged amino acids at P1, which is in contrast to both our explored by further binding studies. Overlapping peptides, 10 amino acids in length, covering the HLA-B7 sequence, were findings, and the motif reported by Kwok et al. (10) . However, 
The binding of the B7 peptides shows a symmetrical pattern either side of the B7 3 peptide. This peptide appears to contain the core binding region and the most likely motif is shown using the negatively charged P1 and P9 anchors. As either the N-or C-terminal amino acids are lost from this core the affinity gradually decreases. this latter motif, based on the binding of a single peptide and It is useful to compare these findings with pool sequence data from HLA-DQ2 as this allele is also associated with analogues, reported mainly residues which were not tolerated in the anchor positions and found the binding of this peptide diabetes mellitus (1) . Both these alleles are also associated with coeliac disease (20); Ͼ90% of patients have HLA-DQ2, was almost entirely dependent on a negatively charged amino acid at P9. Although P9-negative residues clearly enhance the majority of the remainder having -DQ8. Table 5 shows a summary of amino acid enrichments using a derived matrix binding, we did not find it was essential and other anchor residues appear to be important. from a pool sequence for HLA-DQ2 (submitted for publication). The proposed motif is remarkably similar to that derived Although Lys is enriched in the pool sequence in cycles 4/5, the matched ligands do not suggest it has a role as an by binding studies (9, 11) . The anchors are similar to HLA-DQ8, but with some important differences, shown in Table 7 . anchor for P1. The data in the probability matrix shows that the Lys is markedly enriched in cycles 2 and 3, and the These differences may be explained by variation in residues present in the α-and β-chains which are thought to contribute presence in cycles 4/5 could be a reflection of this early enrichment. Lys is often enriched in the early cycles of other to the pockets receiving the anchor residues. Unlike HLA-DQ2, the P1 anchor in -DQ8 appears to allow negatively reported pool sequences (5,14), though it is very rarely implicated as an anchor residue (7). Perhaps its abundance charged amino acids; this may be due to the close proximity of an Arg residue at α53 in -DQ8 which could conceivably in the early cycles reflects a role in antigen processing within the cell.
influence this pocket. Similarly, the increased presence of Table 4 . Matrix generated from the pool sequencing data from HLA-DQ8 .00000 1.00000 1.00000 1.00000 1.00000 1.00000 1.00000 1.00000 1.00000 1.00000 1.00000 1.00000 1.00000 1.00000 1.00000
The eluted peptide ligands were sequenced over 15 cycles by Edman degradation. The total amount of all the amino acids measured in each cycle was summated and each amino acid in this same cycle expressed as a percentage of this total. These percentages were then averaged over the 15 cycles for each amino acid and the amino acid expressed in each cycle as a proportion of the average, as shown in this table. 
Motif differences α53R allows negative β71K allows negative DQ2 favours bulky residues to bind to DQ8 residues in DQ2, not hydrophobic found in DQ8 which may allow Arg Motif similarities bulky hydrophobic aliphatic aliphatic negative polar negative amino acids at P6/7 in HLA-DQ2 may be accounted as a prominent anchor residue in the sequenced ligands. This may be due to the fact that there are many peptides in an eluted for by a Lys residue in the β-chain contributing to these pockets.
pool, and although some use the Arg at P9, they are not present in sufficient concentration to be individually sequenced. HowBoth alleles are β57 Asp-negative; this feature was first noted by Todd et al. to confer susceptibility to IDDM (21).
ever, a similar argument may be applied to its presence in pool data as was used for Lys in the early cycles. It does not feature The presence of Asp may form a salt bridge with an Arg at α79, in a similar fashion as proposed for HLA-DR molecules, as an anchor in other class II alleles and its presence may reflect a general enrichment in the later cycles which again in this case using the Arg at α76 with the β57 Asp (8) . The absence of the salt bridge in Asp-negative alleles could allow may reflect a role in antigen processing. This is outlined in Table  8 which seems to indicate a true enrichment at cycles 12-14 this Arg to favour negatively charged amino acids. Indeed HLA-DRB1*0405, which is the only β57 Asp-negative DR4
for HLA-DQ7 (β57 Asp-positive) and might indicate Arg in this pocket at the C-terminus. subtype, shows a preference for negative amino acids at P9 (6) . This effect has recently been suggested for DQ If the Asp-negative β57 is an important feature for conferring susceptibility to diabetes, it may be possible that shared polymorphisms by comparing the binding of peptides to HLA-DQ7/9 (β57 Asp-positive) with -DQ8 (22). This explanation features of HLA-DQ2 and -DQ8 binding motifs may lead to a consensus susceptibility motif, and that this should be absent could also account for the reduced presence of negatively charged amino acids at the C-terminus in the reported pool from HLA-DQ7. The same reasoning would apply to coeliac disease. One such motif is suggested in Table 7 . Thus, the sequence of peptides eluted from the HLA-DQ7 molecule (14).
Peptides eluted from these above DQ2/8 molecules appear, key feature seems to be the ready acceptance of negatively charged amino acids at P9, along with a bulky hydrophobic from the pool sequencing data, to have relative enrichment of Arg in the later cycles. However, Arg does not seem to feature anchor at P1, and aliphatic residues at P4 and P6/7.
position 86 of the HLA-DR-beta chain. Proc. Natl Acad. Sci. 
